Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07695168Recruiting
Digital course and rehab for knee osteoarthritis
This study tests whether a digital program with special sensors and a digital twin can help reduce knee pain and improve mobility in older adults with knee osteoarthritis. It also includes healthy adults for comparison.
TaipeiAges 20–80 - NCT07689656RecruitingPhase 1/Phase 2
PET imaging study for prostate cancer using a new tracer
This trial tests a new radioactive tracer called ELI421 to see how well it works for PET imaging in people with prostate cancer. It may help doctors find cancer more clearly.
Wuhan, HubeiAges 18–80 - NCT03684655RecruitingPhase 2
PET-MR scan study of immune activity in people with HIV
This Phase 2 study uses a special whole-body scan (PET-MR) to measure immune activity in people living with HIV. It may help researchers understand how well the immune system responds and how to better track HIV-related inflammation.
San Francisco, CaliforniaAges 18 years+ - NCT06651944Recruiting
Invisalign with jaw advancement aligners
This trial tests Invisalign clear aligners that also help move the lower jaw forward. It may be a good fit if you need both teeth straightening and jaw positioning help.
Richmond, British ColumbiaAges 10–16 - NCT06107374RecruitingPhase 2
New imaging for immunotherapy in advanced lung cancer
This trial tests a special imaging scan called [18F]-FARAG to see how well it shows the activity of immunotherapy in advanced NSCLC. The goal is to help doctors understand if the treatment is working earlier than standard scans.
Iowa City, IowaAges 18 years+ - NCT06559436Recruiting
Extending window for clot-busting drug in medium vessel stroke
This trial tests a clot-dissolving drug called tenecteplase given 4.5 to 24 hours after a stroke caused by a blockage in a medium-sized brain artery. It aims to see if waiting longer than usual still helps reduce disability.
Hefei, AnhuiAges 18 years+ - NCT06084806RecruitingPhase 2
Testing reliability of a new PET scan for NSCLC on immunotherapy
This study tests a new PET imaging agent to see how consistently it shows immune activity in the body. It is for people with advanced non-small cell lung cancer who are about to start immunotherapy.
Iowa City, IowaAges 18 years+ - NCT06611345Recruiting
Tumor-treating fields with immunotherapy and chemo for bile duct cancer
This trial is testing a new combination of treatments—a wearable device that sends electric fields to the tumor area (tumor-treating fields) plus immunotherapy (durvalumab) and chemotherapy (gemcitabine/cisplatin)—for people with advanced bile duct or gallbladder cancer. It may be an option if you haven't had chemotherapy for advanced disease before.
HefeiAges 18–75 - NCT06659913Recruiting
Increasing physical activity for body and mind
This study is testing whether increasing physical activity can improve both your body and mind. It's for people who are currently not very active and want to see if moving more makes a difference.
TrondheimAges 12–17 - NCT07680816Recruiting
Study of gamma delta T cells in critically ill patients
This study looks at a type of immune cell called gamma delta T cells in patients who are very sick in the ICU, including those with and without sepsis. The goal is to understand how these cells work differently in these patients, which could help find better treatments.
Wuhan, Outside of the USAges 18–80 - NCT07683117Recruiting
PEP/PrEP through pharmacist prescribing (PEPPI)
This study looks at how well pharmacists can provide PEP and PrEP (HIV prevention pills) using a special software called PEPPI. It aims to make it easier and faster for people to get these medicines.
Del Mar, CaliforniaAges 18 years+ - NCT06662071Recruiting
Personalized bladder cancer treatment using organoid drug testing
This trial tests if using a patient's own tumor cells grown in a lab (organoids) can help choose the best chemotherapy to put directly into the bladder. It is for people with non-muscle invasive bladder cancer who need their first round of this treatment.
Binzhou, ShandongAges 18–80 - NCT07673458RecruitingPhase 1
Testing a new ointment in healthy volunteers
This early-stage study tests a new ointment (YR001) on healthy volunteers to see how it is absorbed through the skin and how safe it is. It helps researchers understand how the ointment behaves in the body before it is tested in people with skin conditions.
Langfang, HebeiAges 18–65 - NCT07672561RecruitingPhase 3
Testing a new pill for moderate to severe plaque psoriasis
This study tests an experimental pill called WD-890 to see if it can help people with moderate to severe plaque psoriasis. The pill is compared to a placebo (a pill with no medicine) to check if it is safe and works well.
Nanjing, JiangsuAges 18–75 - NCT07679048Recruiting
Eye focus test after close-up screen time
This study measures how quickly your eyes refocus after looking at close-up images or videos for a while. It may help researchers understand eye strain from screens.
Rochester, New YorkAges 18–35 - NCT07672795Recruiting
Clot removal treatment for severe stroke in the back of the brain
This study tests whether a minimally invasive procedure to remove a large blood clot from the main artery at the back of the brain can help people who have had a severe stroke. It aims to improve recovery and reduce disability.
Hefei, AnhuiAges 18–85 - NCT07664592RecruitingPhase 3
Comparing toothpastes for sensitive teeth
This trial tests whether a new toothpaste technology can block the tiny tubules in dentin that cause tooth sensitivity. It lasts 2 weeks and will help find better ways to treat sensitive teeth.
Porto Alegre, Rio Grande do SulAges 18–70 - NCT07665216Recruiting
Chatbot for anhedonia and depression
This study tests whether a chatbot-based intervention can improve brain function and reduce symptoms in people who feel very little pleasure or interest (anhedonia) and have depression. You would have MRI scans to see how your brain responds.
Chengdu, SichuanAges 18–40 - NCT07671131Recruiting
Chatbot for helping people who feel little pleasure or joy
This trial tests if a chatbot can improve emotional responses for people with anhedonia (reduced ability to feel pleasure). You will interact with the chatbot and may have brain scans to see changes.
Chengdu, SichuanAges 18–40 - NCT07665242Recruiting
Chatbot therapy for anhedonia and depression
This study tests whether a chatbot-based therapy can help people who feel low pleasure or interest (anhedonia) and depression. It uses brain scans to see how the brain responds to rewards and social situations.
Chengdu, SichuanAges 18–40 - NCT07659574RecruitingPhase 3
Study of UBT251 injection for type 2 diabetes not controlled by diet and exercise
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
Changsha, HunanAges 18–75 - NCT07663019Recruiting
Can a chatbot help with anhedonia and depression?
This study tests whether a friendly chatbot can help people with anhedonia (loss of pleasure) and depression update their beliefs in a more positive way. You'll interact with the chatbot and may have an MRI scan to see how your brain responds.
Chengdu, SichuanAges 18–40 - NCT07660822Recruiting
Game-based exercise for inactive teens
This trial tests if fun, game-based exercise programs can help teens who are not very active get moving. If you're between 10 and 18 and don't have a physical condition that prevents exercise, you may be able to take part.
GaziantepAges 10–18 - NCT05733377Recruiting
Non-invasive scans to study back curve during pregnancy
This trial uses a non-invasive imaging scan to measure a common back curvature called lordosis during pregnancy. Researchers will look at how these measurements relate to birth outcomes in low-risk pregnancies.
Alcalá de Henares, MadridAges 20–40
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.